GF Fund Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
GF Fund Management's NVS Position: Q3 2026 in Review
GF Fund Management held its Novartis (NVS) position steady in Q3 2026 at 2,542 shares worth $362K. The position accounts for ﹤0.01% of the portfolio, ranked #228.
GF Fund Management first reported a position in NVS in Q2 2025 and has held it in 6 quarters since. The position peaked at $589K in Q4 2025. 1,557 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- GF Fund Management held 2,542 shares of Novartis worth $362K as of Q3 2026.
- GF Fund Management left its Novartis share count unchanged in Q3 2026.
- Novartis made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #228 holding.
- GF Fund Management first reported a position in Novartis in Q2 2025 and has held it in 6 quarters since.
- GF Fund Management's Novartis position peaked at $589K in Q4 2025.
- 1,557 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.